Archive | conferences RSS for this section

If you don’t share your pediatric/AYA research with Canadian cancer research community, who will? Last day to submit an abstract is June 14th.

Find instructions for abstract submission here: 
https://conference.ccra-acrc.ca/abstracts/

The Canadian Cancer Research Conference provides an excellent opportunity to present pediatric/AYA research to the cancer community. Abstract submissions from the entire spectrum of research topics are welcome. Trainees (undergraduate students, graduate students, and postdoctoral fellows) and new principal investigators are encouraged to present their work.

The online abstract submission process is bilingual. Abstract submissions will be accepted in both English and French. Abstracts will appear in the language of submission, and posters may be prepared and presented orally in the presenter’s language of choice.


The fifth Canadian Cancer Research Conference will be held from November 3 to 5, 2019 at the Shaw Centre, in Ottawa, Ontario. The last conference was held in 2017 with 1040 conference attendees, 696 abstract submissions, 596 poster presentations, 33 abstract selected speakers, 25 concurrent sessions and 3 plenary sessions.

Abstract submissions for oral and poster presentations will remain open until June 14, 2019.

The scientific program will consist of plenary sessions, concurrent sessions, and poster sessions featuring leading national and international researchers from across the cancer research spectrum.

Collectively, the conference’s scientific program will provide attendees with opportunities to network, learn about cutting-edge research in Canada, and present results to and receive feedback from colleagues from across the country.

Plenary session topics include:

  • Novel Cancer Immunotherapies
  • Cancer Genetics and Precision Oncology
  • Future of Cancer Research

The working list of regular sessions includes:

  • Innovations in Cancer Proteomics
  • Tumour and Immune Microenvironment
  • Pediatric and AYA Oncology
  • Stakeholder/Patient Engagement, Patient Oriented Research
  • Indigenous Populations and Cancer
  • Immunotherapy: Adoptive Cell Therapy
  • Cancer Stem Cells and Cellular Plasticity
  • Rare Cancers
  • Real World Evidence
  • Early Detection and Risk Prediction
  • Mechanisms of Cancer Resistance
  • Model Systems
  • Survivorship
  • Occupational and Environmental Exposure
  • Cancer Imaging and Profiling
  • Integration of Palliative Care Prevention
  • Consortium Based Research
  • Microbiome
  • Lessons from Aging
  • Poor Survival Cancers
  • Equity and Equality
  • Cannabis, Vaping, ECigarettes, and Tobacco
Advertisements

Contribute to the pediatric and AYA presence at the CCRA Canadian Cancer Research Conference by CONTRIBUTING YOUR RESEARCH to the program! Abstracts due by June 14th.

Find instructions for abstract submission here:
https://conference.ccra-acrc.ca/abstracts/

The Canadian Cancer Research Conference provides an excellent opportunity to present pediatric/AYA research to the cancer community. Abstract submissions from the entire spectrum of research topics are welcome. Trainees (undergraduate students, graduate students, and postdoctoral fellows) and new principal investigators are encouraged to present their work.

The online abstract submission process is bilingual. Abstract submissions will be accepted in both English and French. Abstracts will appear in the language of submission, and posters may be prepared and presented orally in the presenter’s language of choice.


The fifth Canadian Cancer Research Conference will be held from November 3 to 5, 2019 at the Shaw Centre, in Ottawa, Ontario. The last conference was held in 2017 with 1040 conference attendees, 696 abstract submissions, 596 poster presentations, 33 abstract selected speakers, 25 concurrent sessions and 3 plenary sessions.

Abstract submissions for oral and poster presentations will remain open until June 14, 2019.

The scientific program will consist of plenary sessions, concurrent sessions, and poster sessions featuring leading national and international researchers from across the cancer research spectrum.

Collectively, the conference’s scientific program will provide attendees with opportunities to network, learn about cutting-edge research in Canada, and present results to and receive feedback from colleagues from across the country.

Plenary session topics include:

  • Novel Cancer Immunotherapies
  • Cancer Genetics and Precision Oncology
  • Future of Cancer Research

The working list of regular sessions includes:

  • Innovations in Cancer Proteomics
  • Tumour and Immune Microenvironment
  • Pediatric and AYA Oncology
  • Stakeholder/Patient Engagement, Patient Oriented Research
  • Indigenous Populations and Cancer
  • Immunotherapy: Adoptive Cell Therapy
  • Cancer Stem Cells and Cellular Plasticity
  • Rare Cancers
  • Real World Evidence
  • Early Detection and Risk Prediction
  • Mechanisms of Cancer Resistance
  • Model Systems
  • Survivorship
  • Occupational and Environmental Exposure
  • Cancer Imaging and Profiling
  • Integration of Palliative Care Prevention
  • Consortium Based Research
  • Microbiome
  • Lessons from Aging
  • Poor Survival Cancers
  • Equity and Equality
  • Cannabis, Vaping, ECigarettes, and Tobacco

CCRA Conference (Ottawa) Call for Abstracts – now open | submit by 14-June-2019

The Canadian Cancer Research Alliance (CCRA) is now accepting abstracts for poster, oral and rapid fire presentations for the 2019 Canadian Cancer Research Conference(#CCRAconf) taking place November 3 to 5, 2019 at the Shaw Centre in Ottawa, Ontario.

The abstract submission deadline is June 14, 2019.

View the preliminary scientific program here.

SUBMIT AN ABSTRACT
Questions?

For more information, visit the CCRA website. The CCRA looks forward to seeing you in Ottawa!

CLICK NOW for agenda and registration for the ENACT symposium at Sick Kids | Learn about translating innovative research tests into clinical care (June 12th)

Register now at www.eventbrite.com/e/symposium-next-generation-research-testing-tickets-60057100404

This multidisciplinary meeting will highlight emerging challenges and opportunities in test development through transnational research, and will bring together experts to address current limitations of provincial regulations for novel testing.

Date:
June 12th, 2019
Time:10:00 am – 4:00 pm
Place:SickKids, PGCRL Auditorium, 686 Bay St, Toronto
Agenda:

10:00 – 10:20am Welcome and Introduction
Dr. Ronald Cohn, MD, FACMG, Incoming CEO, SickKids; Dr. Michael Salter, MD, PhD, FRSC, Chief of Research, SickKids; Dr. Meredith Irwin, MD, Co-Chair ENACT Committee, Associate Chair (Research) Paediatrics, SickKids; Dr. Rulan Parekh, MD, MS, FRCP(C), FASN, Co-Chair ENACT Committee, Associate Chief of Clinical Research, SickKids

10:20 – 11:20am Keynote Address
Dr. Jeffrey Botkin, MD, MPH, Chair of National Academies of Sciences, Engineering & Medicine Committee that authored “Returning Individual Research Results to Participants” will discuss the reaction to the report, as well as other issues and challenges that have arisen in this area.

11:20 – 11:30am Coffee Break

11:30 – 12:10pm Test Development and Implementation
Dr. Wendy Ungar PhD, Chair of Ontario Genetic Advisory Committee, Health Quality Ontario; Dr. Susan Richardson, MD, FRCP(C), Senior Associate Scientist Emeritus, Research Institute, SickKids, Adjunct Scientist, Public Health Laboratories, Public Health Ontario

12:10 – 12:30pm The Next Frontier: Whole Genome Testing
Dr. Christian Marshall, PhD, Director, Molecular Genetics, SickKids

12:30 – 1:15pm Lunch

1:15 – 1:45pm Cancer Gene Panel Development
Dr. Adam Shlien, PhD, Associate Director of Translational Genetics, SickKids

1:45 – 3:30pm Testing Innovation Panel Discussions
Moderators: Dr. Gabrielle Boulianne, PhD, Associate Chief, Science Strategy & Innovation, SickKids; Dr. George Yousef, MD, PhD, Chief, Paediatric Laboratory Medicine, SickKids
Panellists: TBD

3:30pm Concluding Remarks and Next Steps
Dr. Meredith Irwin, MD, Associate Chair (Research) Paediatrics, SickKids; Dr. Rulan Parekh, MD, MS, FRCP(C), FASN, Associate Chief of Clinical Research, SickKids

SickKids leadership assembled the ENACT (ENAbling Clinical Translation) committee to examine and address issues related to the development and use of novel tests to guide clinical diagnosis, prevention or treatment. Comprised of clinicians, clinician scientists, basic researchers, legal experts and bioethicists, the ENACT committee is working to create guidelines and policies for tests not currently covered by regulations; make recommendations around the development, use and validation of novel tests and return of results; and develop processes to provide access to innovative research tests and ultimately translate clinically validated tests into care.

Canadian Cancer Research Conference is in Ottawa, Nov 3-5 |Preliminary program available now | Abstract submission opens April 18th | Pediatric & AYA session on Sunday Nov 3

The preliminary program is now available for the upcoming Canadian Cancer Research Conference (CCRC) taking place November 3 to 5, 2019 at the Shaw Centre in Ottawa, Ontario. Please check back often to see updates to the program, sessions and speakers as more details are confirmed.  Abstract submissions for oral presentations and posters will open on April 18, 2019. We invite researchers at all stages of their career to submit an abstract for a chance to present their work to research professionals from across the country.

Attend the ENACT symposium at Sick Kids on June 12th to learn about translating innovative research tests into clinical care

Sign up to be notified when registration opens.

This multidisciplinary meeting will highlight emerging challenges and opportunities in test development through transnational research, and will bring together experts to address current limitations of provincial regulations for novel testing.

Keynote:Dr. Jeffrey Botkin
Chair of National Academies of Sciences,
Engineering & Medicine Committee that
Authored Returning Individual Research Results to Patients
Date:
June 12th, 2019
Time:10:00 am – 4:00 pm
Place:SickKids, PGCRL Auditorium
686 Bay St, Toronto

SickKids leadership assembled the ENACT (ENAbling Clinical Translation) committee to examine and address issues related to the development and use of novel tests to guide clinical diagnosis, prevention or treatment. Comprised of clinicians, clinician scientists, basic researchers, legal experts and bioethicists, the ENACT committee is working to create guidelines and policies for tests not currently covered by regulations; make recommendations around the development, use and validation of novel tests and return of results; and develop processes to provide access to innovative research tests and ultimately translate clinically validated tests into care.

Join your fellow researchers at the 5th Canadian Cancer Research Conference, to be held November 3 to 5, 2019 at the Shaw Centre, in Ottawa, Ontario. Pediatric/AYA specific session on Sunday Nov 3rd.

The fifth Canadian Cancer Research Conference will be held from November 3 to 5, 2019 at the Shaw Centre, in Ottawa, Ontario. The last conference was held in 2017 with 1040 conference attendees, 696 abstract submissions, 596 poster presentations, 33 abstract selected speakers, 25 concurrent sessions and 3 plenary sessions.

Abstract submissions for oral and poster presentations will open April 15, 2019, until June 14, 2019.

The scientific program will consist of plenary sessions, concurrent sessions, and poster sessions featuring leading national and international researchers from across the cancer research spectrum.

Collectively, the conference’s scientific program will provide attendees with opportunities to network, learn about cutting-edge research in Canada, and present results to and receive feedback from colleagues from across the country.

Plenary session topics include:

  • Novel Cancer Immunotherapies
  • Cancer Genetics and Precision Oncology
  • Future of Cancer Research

The working list of regular sessions includes:

  • Innovations in Cancer Proteomics
  • Tumour and Immune Microenvironment
  • Pediatric and AYA Oncology
  • Stakeholder/Patient Engagement, Patient Oriented Research
  • Indigenous Populations and Cancer
  • Immunotherapy: Adoptive Cell Therapy
  • Cancer Stem Cells and Cellular Plasticity
  • Rare Cancers
  • Real World Evidence
  • Early Detection and Risk Prediction
  • Mechanisms of Cancer Resistance
  • Model Systems
  • Survivorship
  • Occupational and Environmental Exposure
  • Cancer Imaging and Profiling
  • Integration of Palliative Care Prevention
  • Consortium Based Research
  • Microbiome
  • Lessons from Aging
  • Poor Survival Cancers
  • Equity and Equality
  • Cannabis, Vaping, ECigarettes, and Tobacco

Remember to Register! ADOLESCENT & YOUNG ADULT SURVIVORSHIP SYMPOSIUM: A NEW VISION (March 20-21, 2019 in Toronto)

https://uhnevents.regfox.com/aya-survivorship-symposium

Hotel block closes February 17th.

The Adolescent and Young Adult Survivorship Symposium: A New Vision aims to engage local, national and international experts and trainees to build a framework for the delivery of survivorship care for survivors of young adult cancer.

Keynote Speaker:

Dr. Lois Travis, MD, ScD
Director of the Cancer Survivorship Research Program
Melvin and Bren Simon Cancer Centre, Indiana University

Day 1: How Can a Program Can Help Young Adults with Cancer?

Learn about and develop skills in identifying, assessing and intervening on the unique needs of young adults with cancer. Participants will gain an understanding of effective models of care for addressing AYA-specific issues.

Day 2: Surveillance and Screening for Survivors of Adolescent and Young Adult Cancer

Participants will have increased awareness and knowledge of common treatment-related late effects in younger adult cancer survivors and evidence-based interventions for managing them.

See link for registration, agenda, location, contact information and accommodation details.  https://uhnevents.regfox.com/aya-survivorship-symposium

ADOLESCENT & YOUNG ADULT SURVIVORSHIP SYMPOSIUM: A NEW VISION (March 20-21, 2019 in Toronto)

https://uhnevents.regfox.com/aya-survivorship-symposium

The Adolescent and Young Adult Survivorship Symposium: A New Vision aims to engage local, national and international experts and trainees to build a framework for the delivery of survivorship care for survivors of young adult cancer.

Keynote Speaker:

Dr. Lois Travis, MD, ScD
Director of the Cancer Survivorship Research Program
Melvin and Bren Simon Cancer Centre, Indiana University

Day 1: How Can a Program Can Help Young Adults with Cancer?

Learn about and develop skills in identifying, assessing and intervening on the unique needs of young adults with cancer. Participants will gain an understanding of effective models of care for addressing AYA-specific issues.

Day 2: Surveillance and Screening for Survivors of Adolescent and Young Adult Cancer

Participants will have increased awareness and knowledge of common treatment-related late effects in younger adult cancer survivors and evidence-based interventions for managing them.

See link for registration, agenda, location, contact information and accommodation details.  https://uhnevents.regfox.com/aya-survivorship-symposium

Oh, Canada! Proceedings from DIA Canada 2018

Let your fingers do the walking this morning: Venture to Ottawa, Ontario, and read expert reports from our recent DIA Annual Canadian Meeting 2018 in your new Global Forum.

Last Call: Please take this five-minute Global Forum Readers’ Survey to tell us how we’ve done since our new re-design and a $100 gift card may be yours!

EXPLORE DIA CANADA 2018
Thank you for your loyal readership!